These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 28904510)

  • 21. Cognitive impairments in patients with first episode psychosis: The relationship between neurophysiological and neuropsychological assessments.
    Morales-Muñoz I; Jurado-Barba R; Fernández-Guinea S; Álvarez-Alonso MJ; Rodríguez-Jiménez R; Jiménez-Arriero MA; Rubio G
    J Clin Neurosci; 2017 Feb; 36():80-87. PubMed ID: 27825609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
    Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
    Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Effects of oxidative stress on cognitive impairment in first episode schizophrenia].
    Wang YP; Zhang PF; Yuan XX; Liu YF; Li HH; Tao Q; Li X; Pang LJ; Song XQ
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(1):9-13. PubMed ID: 30641657
    [No Abstract]   [Full Text] [Related]  

  • 24. Use of the MATRICS consensus cognitive battery (MCCB) to evaluate cognitive deficits in bipolar disorder: A systematic review and meta-analysis.
    Bo Q; Mao Z; Li X; Wang Z; Wang C; Ma X
    PLoS One; 2017; 12(4):e0176212. PubMed ID: 28437438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor analyzing the Norwegian MATRICS Consensus Cognitive Battery.
    Mohn C; Lystad JU; Ueland T; Falkum E; Rund BR
    Psychiatry Clin Neurosci; 2017 May; 71(5):336-345. PubMed ID: 28182301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.
    Rodriguez-Toscano E; López G; Mayoral M; Lewis S; Lees J; Drake R; Arango C; Rapado-Castro M
    Schizophr Res; 2020 Feb; 216():347-356. PubMed ID: 31813804
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia.
    Zhao N; Wang XH; Kang CY; Zheng Y; Yang LY; Guan TF; Bai YX; Wei R; Hinman HC; Zhang XY
    Ann Gen Psychiatry; 2021 Apr; 20(1):26. PubMed ID: 33882965
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cognitive deficit in schizophrenia: MATRICS Consensus Cognitive Battery].
    Rodríguez-Jiménez R; Bagney A; Moreno-Ortega M; García-Navarro C; Aparicio AI; López-Antón R; de la Oliva J; Jiménez-Arriero MÁ; Santos JL; Lobo A; Palomo T
    Rev Neurol; 2012 Nov; 55(9):549-55. PubMed ID: 23111994
    [TBL] [Abstract][Full Text] [Related]  

  • 30. What is the optimal neuropsychological test battery for schizophrenia in China?
    Shi C; Kang L; Yao S; Ma Y; Li T; Liang Y; Cheng Z; Xu Y; Shi J; Xu X; Zhang C; Franklin DR; Heaton RK; Jin H; Yu X
    Schizophr Res; 2019 Jun; 208():317-323. PubMed ID: 30718121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial.
    Lees J; Michalopoulou PG; Lewis SW; Preston S; Bamford C; Collier T; Kalpakidou A; Wykes T; Emsley R; Pandina G; Kapur S; Drake RJ
    Psychol Med; 2017 Oct; 47(13):2358-2368. PubMed ID: 28464963
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia.
    Chen S; Tian L; Chen N; Xiu M; Wang Z; Yang G; Wang C; Yang F; Tan Y
    Psychiatry Res; 2017 Jan; 247():6-11. PubMed ID: 27863321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients.
    Georgiades A; Davis VG; Atkins AS; Khan A; Walker TW; Loebel A; Haig G; Hilt DC; Dunayevich E; Umbricht D; Sand M; Keefe RSE
    Schizophr Res; 2017 Dec; 190():172-179. PubMed ID: 28433500
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China.
    Shi C; Kang L; Yao S; Ma Y; Li T; Liang Y; Cheng Z; Xu Y; Shi J; Xu X; Zhang C; Franklin DR; Heaton RK; Jin H; Yu X
    Schizophr Res; 2015 Dec; 169(1-3):109-115. PubMed ID: 26441005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MCCB cognitive profile in Spanish first episode schizophrenia patients.
    Rodriguez-Jimenez R; Santos JL; Dompablo M; Santabárbara J; Aparicio AI; Olmos R; Jiménez-López E; Sánchez-Morla E; Lobo A; Palomo T; Kern RS; Green MF; Nuechterlein KH; García-Fernández L
    Schizophr Res; 2019 Sep; 211():88-92. PubMed ID: 31345706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Brazilian standardization of the MATRICS consensus cognitive battery (MCCB): Psychometric study.
    Fonseca AO; Berberian AA; de Meneses-Gaya C; Gadelha A; Vicente MO; Nuechterlein KH; Bressan RA; Lacerda ALT
    Schizophr Res; 2017 Jul; 185():148-153. PubMed ID: 28110814
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A confirmatory factor analysis of the MATRICS consensus cognitive battery in severe mental illness.
    Lo SB; Szuhany KL; Kredlow MA; Wolfe R; Mueser KT; McGurk SR
    Schizophr Res; 2016 Aug; 175(1-3):79-84. PubMed ID: 27041675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sex differences in association between clinical correlates and cognitive impairment in patients with chronic schizophrenia.
    Mu L; Liang J; Wang H; Chen D; Xiu M; Zhang XY
    J Psychiatr Res; 2020 Dec; 131():194-202. PubMed ID: 32980647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study.
    Kern RS; Gold JM; Dickinson D; Green MF; Nuechterlein KH; Baade LE; Keefe RS; Mesholam-Gately RI; Seidman LJ; Lee C; Sugar CA; Marder SR
    Schizophr Res; 2011 Mar; 126(1-3):124-31. PubMed ID: 21159492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of cognitive dysfunction between schizophrenia and bipolar disorder patients: A meta-analysis of comparative studies.
    Li W; Zhou FC; Zhang L; Ng CH; Ungvari GS; Li J; Xiang YT
    J Affect Disord; 2020 Sep; 274():652-661. PubMed ID: 32663999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.